Nadia Zaffaroni

26.6k total citations · 2 hit papers
351 papers, 13.0k citations indexed

About

Nadia Zaffaroni is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nadia Zaffaroni has authored 351 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Molecular Biology, 91 papers in Oncology and 76 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nadia Zaffaroni's work include RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (40 papers) and Telomeres, Telomerase, and Senescence (34 papers). Nadia Zaffaroni is often cited by papers focused on RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (40 papers) and Telomeres, Telomerase, and Senescence (34 papers). Nadia Zaffaroni collaborates with scholars based in Italy, United States and United Kingdom. Nadia Zaffaroni's co-authors include Maria Grazia Daidone, Marco Folini, Marzia Pennati, Paolo Gandellini, Raffaella Villa, Giovanni Luca Beretta, Aurora Costa, Silvana Pilotti, Marco A. Pierotti and Giovanna Petrangolini and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Nadia Zaffaroni

342 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties

2005 1.4k citations Nadia Zaffaroni, Graziella Pratesi et al. Cancer Research profile →
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-termIn vitroCulture and Do Not Exhibit Telomere Maintenance Mechanisms

2007 539 citations Nadia Zaffaroni, Maria Grazia Daidone et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadia Zaffaroni Italy	57	8.0k	3.8k	2.8k	1.8k	994	351	13.0k
Yun Yen United States	62	9.1k 1.1×	4.2k 1.1×	3.5k 1.2×	1.4k 0.8×	524 0.5×	369	15.2k
Gerald McMahon United States	45	7.0k 0.9×	3.1k 0.8×	2.9k 1.0×	1.4k 0.8×	1.0k 1.0×	77	11.8k
Ian J. Stratford United Kingdom	63	7.6k 0.9×	3.9k 1.0×	5.9k 2.1×	2.1k 1.2×	1.9k 1.9×	345	15.7k
Dean W. Felsher United States	59	9.7k 1.2×	4.6k 1.2×	3.6k 1.3×	1.5k 0.9×	369 0.4×	176	15.9k
Helen Turley United Kingdom	65	10.0k 1.2×	3.9k 1.0×	7.4k 2.7×	2.0k 1.1×	444 0.4×	149	15.9k
Motowo Nakajima Japan	54	5.9k 0.7×	2.7k 0.7×	2.2k 0.8×	1.1k 0.6×	713 0.7×	225	10.3k
Beverly A. Teicher United States	67	8.7k 1.1×	7.5k 2.0×	4.2k 1.5×	2.3k 1.3×	946 1.0×	396	18.1k
Bonnie F. Sloane United States	64	6.8k 0.8×	4.3k 1.1×	6.4k 2.3×	992 0.6×	588 0.6×	211	14.5k
Arne Östman Sweden	63	9.8k 1.2×	4.6k 1.2×	2.9k 1.0×	1.8k 1.0×	313 0.3×	165	16.8k
David A. Boothman United States	67	7.8k 1.0×	3.6k 0.9×	2.1k 0.8×	1.5k 0.9×	2.2k 2.2×	194	13.8k

Countries citing papers authored by Nadia Zaffaroni

Since Specialization

Citations

This map shows the geographic impact of Nadia Zaffaroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Zaffaroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Zaffaroni more than expected).

Fields of papers citing papers by Nadia Zaffaroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Zaffaroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Zaffaroni. The network helps show where Nadia Zaffaroni may publish in the future.

Co-authorship network of co-authors of Nadia Zaffaroni

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Zaffaroni. A scholar is included among the top collaborators of Nadia Zaffaroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Zaffaroni. Nadia Zaffaroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gallina, Irene, Lorenzo Di Pietro, Loredana Cleris, et al.. (2025). The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levels. Nucleic Acids Research. 53(4). 3 indexed citations

Cameron, Daniel, Nadia Zaffaroni, Noemi Arrighetti, et al.. (2025). Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas. Journal of Clinical Investigation. 135(20).

Pietrantonio, Filippo, Federica Morano, Monica Niger, et al.. (2024). The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial. Clinical Cancer Research. 31(4). 649–658. 2 indexed citations

Stacchiotti, Silvia, Giacomo Giulio Baldi, Anna Maria Frezza, et al.. (2023). Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study. European Journal of Cancer. 195. 113391–113391. 8 indexed citations

Maciejewska, Natalia, Maciej Bagiński, Maryna Stasevych, et al.. (2022). Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres. Cell Death and Disease. 13(11). 1005–1005. 12 indexed citations

Gandellini, Paolo, Chiara Maura Ciniselli, T. Rancati, et al.. (2021). Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables. Cancers. 13(10). 2433–2433. 9 indexed citations

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.. (2018). Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma. EBioMedicine. 39. 215–225. 47 indexed citations

Cicchetti, A., F. Palorini, Tiziana Magnani, et al.. (2018). Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy. Disease Markers. 2018. 1–9. 16 indexed citations

Antoniotti, Carlotta, Federica Marmorino, Marzia Pennati, et al.. (2017). Circulating angiogenesis-related markers as predictors of benefit from regorafenib in metastatic colorectal cancer (mCRC) patients (pts). Annals of Oncology. 28. vi4–vi4. 3 indexed citations

10.

Rivoltini, Licia, Claudia Chiodoni, Paola Squarcina, et al.. (2016). TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site. Clinical Cancer Research. 22(14). 3499–3512. 164 indexed citations

11.

Gandellini, Paolo, Elisa Giannoni, Maria Letizia Taddei, et al.. (2013). miR-205 Hinders the Malignant Interplay Between Prostate Cancer Cells and Associated Fibroblasts. Antioxidants and Redox Signaling. 20(7). 1045–1059. 66 indexed citations

12.

Stacchiotti, Silvia, Fabio Bozzi, Elena Tamborini, et al.. (2013). Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics. Clinical Cancer Research. 19(18). 5192–5201. 53 indexed citations

13.

Cesare, Michelandrea De, Calogero Lauricella, Silvio Veronese, et al.. (2013). Synergistic Antitumor Activity of Cetuximab and Namitecan in Human Squamous Cell Carcinoma Models Relies on Cooperative Inhibition of EGFR Expression and Depends on High EGFR Gene Copy Number. Clinical Cancer Research. 20(4). 995–1006. 6 indexed citations

14.

Tassi, Elena, Claudia Vegetti, Alessandra Molla, et al.. (2012). Role of Apollon in Human Melanoma Resistance to Antitumor Agents That Activate the Intrinsic or the Extrinsic Apoptosis Pathways. Clinical Cancer Research. 18(12). 3316–3327. 27 indexed citations

15.

Sommariva, Michele, Loris De Cecco, Michelandrea De Cesare, et al.. (2011). TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects. Cancer Research. 71(20). 6382–6390. 36 indexed citations

16.

Gandellini, Paolo, Marco Folini, Nicole Longoni, et al.. (2009). miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε. Cancer Research. 69(6). 2287–2295. 293 indexed citations

17.

Lopergolo, Alessia, Marzia Pennati, Paolo Gandellini, et al.. (2009). Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. British Journal of Cancer. 100(5). 739–746. 43 indexed citations

18.

Bajetta, Emilio, Simonetta Chiara Stani, Nadia Zaffaroni, et al.. (2003). Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IVnon-small-cell lung cancer. Annals of Oncology. 14(2). 242–247. 15 indexed citations

19.

Bearzatto, Alessandra, L. Orlandi, Cinzia De Marco, Maria Grazia Daidone, & Nadia Zaffaroni. (1999). Lack of p21waf1 and p27kip1 protein induction by interferon-α2a in human melanoma cell lines. Melanoma Research. 9(5). 457–464. 5 indexed citations

20.

Zaffaroni, Nadia, et al.. (1979). Peripheral blood cells in the crested newt after long-term exposure to the fungicide manganese ethylenebisdithiocarbamate (Maneb). Bulletin of Environmental Contamination and Toxicology. 23(1). 587–591.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact